Cancer innovations

11:50 AM ET Fri, 28 July 2017

Dr. Laurie Glimcher, CEO of Dana-Farber Cancer Institute shares how immunotherapy drugs and precision medicine are yielding progress. But government and insurance uncertainty is creating challenges for patients and providers on how to pay for experimental therapies to combat the disease.